The U.S. Department of Veterans Affairs issued notice of a policy change regarding covered drugs not compliant with the Trade Agreements Act (TAA) of 1979. Previously, the VA required that all products offered on the Federal Supply Schedule (FSS) contract be U.S.-made or substantially transformed designated country end products.